Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 22.12
Key Takeaways
Risk factor
Meaningful price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Zhejiang East Asia Pharmaceutical Co., Ltd. engages in the manufacture and distribution of active pharmaceutical ingredients (API), tablets, granules and capsules. The company was founded in 1992 and is headquartered in Taizhou, China.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBIT
Data is available to registered users only
Buy
Sell